Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

CHIR-124, a novel small-molecule quinolone-based inhibitor of the CHK1 checkpoint

April 2, 2004

Radioimmunotherapy with 131I-cG250 assessed in renal cell carcinoma

April 2, 2004

Final statistical plan agreed for two pivotal Targretin trials

April 2, 2004

Axcan receives European marketing approval for Photobarr PDT

April 2, 2004

Potent syncretic antimitotic agent by CombinatoRx

April 2, 2004

Congress presentations report PD-0332991's biochemical, pharmacological and pharmacokinetic profile

April 1, 2004

Pladienolide D derivative, E-7107, shows good antitumor activity in xenografts

April 1, 2004

Bayer claims diagnostics and therapeutics for GPR19-associated diseases

April 1, 2004

Enrollment opens in phase III trial of STR in multiple myeloma

April 1, 2004

YM BioSciences to commence pivotal tesmilifene trial in coming weeks

April 1, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 31, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026